Late radiation morbidity in a patient with carcinoma of the cervix.
暂无分享,去创建一个
[1] Jacqueline P. Williams,et al. Radiation-Induced Pulmonary Fibrosis: Examination of Chemokine and Chemokine Receptor Families , 2002, Radiation research.
[2] R. Stock,et al. ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects. , 2002, International journal of radiation oncology, biology, physics.
[3] C. West,et al. Differential Expression of Cytokine Genes in Fibroblasts Derived from Skin Biopsies of Patients who Developed Minimal or Severe Normal Tissue Damage after Radiotherapy , 2002, Radiation research.
[4] S. Roberts,et al. Lymphocyte radiosensitivity is a significant prognostic factor for morbidity in carcinoma of the cervix. , 2001, International journal of radiation oncology, biology, physics.
[5] A. Flynn,et al. Principles and Practice of Brachytherapy: Using Afterloading Systems , 2001 .
[6] E. Choi,et al. Effect of protein kinase C inhibitor (PKCI) on radiation sensitivity and c-fos transcription. , 2001, International journal of radiation oncology, biology, physics.
[7] O. Pradier,et al. In vitro response of human dermal fibroblasts to X-irradiation: relationship between radiation-induced clonogenic cell death, chromosome aberrations and markers of proliferative senescence or differentiation , 2001, International journal of radiation biology.
[8] U Oppitz,et al. The in vitro colony assay: a predictor of clinical outcome , 2001, International journal of radiation biology.
[9] Sally A. Amundson,et al. Identification of Potential mRNA Biomarkers in Peripheral Blood Lymphocytes for Human Exposure to Ionizing Radiation , 2000, Radiation research.
[10] J. Yarnold,et al. Cellular radiosensitivity and complication risk after curative radiotherapy. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[11] J. Hendry,et al. A correlation between residual radiation-induced DNA double-strand breaks in cultured fibroblasts and late radiotherapy reactions in breast cancer patients. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[12] J. Peacock,et al. Describing patients' normal tissue reactions: Concerning the possibility of individualising radiotherapy dose prescriptions based on potential predictive assays of normal tissue radiosensitivity , 1998, International journal of cancer.
[13] A. Hart,et al. Low predictive value of intrinsic fibroblast radiosensitivity for fibrosis development following radiotherapy for breast cancer. , 1998, International journal of radiation biology.
[14] J Nyman,et al. Prognostic factors for acute and late skin reactions in radiotherapy patients. , 1996, International journal of radiation oncology, biology, physics.
[15] S M Bentzen,et al. Evidence for a positive correlation between in vitro radiosensitivity of normal human skin fibroblasts and the occurrence of subcutaneous fibrosis after radiotherapy. , 1994, International journal of radiation biology.
[16] R. Wurm,et al. Prediction of normal-tissue tolerance to radiotherapy from in-vitro cellular radiation sensitivity , 1992, The Lancet.
[17] E. Easson,et al. The Radiotherapy of Malignant Disease , 1991, Springer London.
[18] R. Clough,et al. Plasma transforming growth factor β1 as a predictor of radiation pneumonitis , 1997 .
[19] H. Bartelink,et al. Use of fluorescence in situ hybridization to determine the relationship between chromosome aberrations and cell survival in eight human fibroblast strains. , 1995, International journal of radiation biology.
[20] S. Roberts,et al. Use of low-dose rate irradiation to measure the intrinsic radiosensitivity of human T-lymphocytes. , 1993, International journal of radiation biology.
[21] V. Blair,et al. A clinical trial of two conceptually different radical radiotherapy treatments in stage III carcinoma of the cervix. , 1986, Clinical radiology.